Sierra Rheumatology
Medication consent

Informed Consent for Treatment with Rituximab (Rituxan / Truxima / Ruxience)

Informed consent for treatment with Rituximab.

About this form

Rituximab is a monoclonal antibody used to treat rheumatoid arthritis, certain forms of vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis), and other autoimmune and hematologic conditions. It targets and depletes B-cells.

  • !Severe and sometimes fatal infusion reactions; premedication is given.
  • !Reactivation of hepatitis B can occur — screening is required.
  • !Increased risk of infections, including serious viral and bacterial infections.
  • !Rare cases of progressive multifocal leukoencephalopathy (PML).
  • !Tumor lysis syndrome and severe mucocutaneous reactions reported in cancer settings.
Progress
0%
Patient information
Benefits
I understand that the potential benefits of this treatment include: *
Common side effects
I have been informed of the most common side effects, which include: *
Acknowledgements
I have had the opportunity to discuss this treatment with my physician. *
All of my questions have been answered to my satisfaction. *
I understand my financial responsibility for this treatment. *
Sign & submit
Patient signature *Sign with your finger, mouse or trackpad in the box below.
Sign here with your finger, mouse or trackpad

Your signature will appear on the exported PDF.

Acknowledgement. I certify that I have read and understood this consent form, that I have had the opportunity to discuss it with my physician, and that I agree to receive treatment with Rituximab.

Submitting transmits this form securely to our office. Export to PDF works even with partial answers — useful if you want a printed copy to bring in. For urgent medical issues, please call our office or 911.

Trouble with the form?

Call our office and we'll either walk you through it or send a paper version.